Data analyses from two real-world trials of Rebyota (fecal microbiota, live-jslm)efficacy and safety will be presented at IDWeek 2025, according to the details of a recent Ferring Pharmaceuticals news ...

An opportunistic bacterial infection that causes deadly diarrhea is more likely to kill White patients than Black or Hispanic ...

The data also showed notable geographic differences in CDI deaths, with 83.8% occurring in and around large urban areas and ...

More than four out of five deaths (83.9%) were in white patients. That group is more likely to be exposed to risk factors ...

The panelist discusses how recurrent Clostridioides difficile infections involve complex differential diagnosis, including persistent infection, reinfection, and other gastrointestinal conditions.

Clostridium difficile bacteria, 3D illustration. Spore-forming bacteria that cause pseudomembraneous colitis and are associated with nosocomial antibiotic resistance Fecal transplant performs as well ...

Neil Minkoff, MD: Let me ask a question to the whole group. I’m not trying to cause a rift between our panelists here, but Dr Allegretti or Dr Gerding, do you have difficulty getting procedures ...

STATEN ISLAND, N.Y., Dec. 9, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule ...

Adding aerosolized hydrogen peroxide to infection prevention protocols reduces the risk of Clostridioides difficile infections in healthcare settings, according to a study published March 17 in the ...

Nearly half a million people in the United States suffer from an intestinal infection called Clostridium difficile each year. Approximately half of those individuals become sick enough to require ...

Some of the key facts of the Clostridium Difficile Infections Market Report: ...